← Leaderboards
Vivek Swarup
University Of California-Irvine
$6,264,299
Attributed
$11,424,793
Total exposure
7
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2021–25$5M$3.8M$2.5M$1.3M$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,424,793 · 7
By mechanism
RF1$4,389,376 · 2
R01$3,781,442 · 3
U01$2,755,296 · 1
T32$498,679 · 1
Top collaborators
- Tallie Z. Z Baram4 shared
- Christie D Fowler4 shared
- Stephen Vincent Mahler4 shared
- Denes Agoston3 shared
- Andre Obenaus3 shared
- Masashi Kitazawa2 shared
- Craig E Stark1 shared
- Jing Zhang1 shared
Most similar at University Of California-Irvine
Same institution · by research overlap
- Andre Obenaus$7,372,565
- Elizabeth Head$28,076,061
- Christie D Fowler$8,621,482
- Michael A Yassa$21,614,052
- Chang C Liu$12,255,496
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposCellsTranscriptomicsGene ExpressionS DiseaseSex DifferencesInsightAffectExperimental StudyGeneticSingle Nucleus Rna-SequencingSamplingReportingS Disease ModelGenesGenetic TranscriptionMolecularMouse ModelNeuronsCell TypeS Disease RiskEpigenomicsBehavioralAtac-Seq
Grant awards (14)
Dynamic epigenomic landscape of opioid abuse following early-life adversity$691,904
U01 · FY2025 · DA
Neurotoxicity of particulate matter and its interaction with APOE in neurodegeneration$688,560
R01 · FY2025 · NS
Oligodendrocyte heterogeneity in Alzheimer' s disease$605,965
R01 · FY2025 · AG · contact PI
Molecular Markers of Cerebrovascular Pathologies in Alzheimer's Disease and Related Dementias$573,533
R01 · FY2025 · NS
Training in the Neurobiology of Aging and Alzheimers Disease$498,679
T32 · FY2025 · AG
Dynamic epigenomic landscape of opioid abuse following early-life adversity$691,904
U01 · FY2024 · DA
Molecular Markers of Cerebrovascular Pathologies in Alzheimer's Disease and Related Dementias$614,893
R01 · FY2024 · NS
Oligodendrocyte heterogeneity in Alzheimer' s disease$614,055
R01 · FY2024 · AG · contact PI
Harmonization and Joint Analysis of Human Brain Single-Cell Datasets$344,508
RF1 · FY2024 · AG · contact PI
Dynamic epigenomic landscape of opioid abuse following early-life adversity$702,093
U01 · FY2023 · DA
Molecular Markers of Cerebrovascular Pathologies in Alzheimer's Disease and Related Dementias$684,436
R01 · FY2023 · NS
Neurotoxicity of particulate matter and its interaction with APOE in neurodegeneration$2,159,148
RF1 · FY2022 · NS
Dynamic epigenomic landscape of opioid abuse following early-life adversity$669,395
U01 · FY2022 · DA
Oligodendrocyte heterogeneity in Alzheimer' s disease$1,885,720
RF1 · FY2021 · AG · contact PI